The present invention relates to the use of agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, in obtaining medicaments intended for the treatment of Generalized Anxiety Disorder.

 
Web www.patentalert.com

> Structural carotenoid analogs or derivatives for the modulation of systemic and/or target organ redox status
~ 00383